ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Why “Normal Labs” Are Failing Millions — And Why Opti Metabolics Built a Different Model

AUSTIN, TX - January 12, 2026 - PRESSADVANTAGE -

For millions of Americans, fatigue, stubborn weight gain, declining energy, and brain fog aren’t sudden problems. They’re early metabolic warning signals, often dismissed because standard lab results appear “normal.”

Opti Metabolics was built to address that gap.

Based in Austin, Texas, Opti Metabolics is a proactive metabolic health company founded on a simple belief: waiting for disease is the wrong model. Its approach is designed to help individuals understand metabolic dysfunction earlier, before those issues progress into more serious, long-term conditions.

“Most chronic disease doesn’t begin with a diagnosis,” said Kevin Bury, Co-founder of Opti Metabolics. “It begins quietly, with small signals people often ignore because their labs fall within wide reference ranges. We built Opti to help people understand what their data is actually saying, before those signals turn into lifelong conditions.”

“In medicine, we’re trained to diagnose disease once clinical thresholds are crossed,” said Dr. Brent Brotzman, Chief Medical Officer of Opti Metabolics. “But metabolic dysfunction develops quietly over years. By the time labs are flagged as abnormal, the process is already well underway. The opportunity we’re missing is earlier understanding—when change is still far more effective.”

Research suggests that metabolic dysfunction can develop 20+ years before conditions such as type 2 diabetes, heart disease, or metabolic syndrome are diagnosed. Yet today’s healthcare model is designed to respond only after disease thresholds are crossed.

Opti Metabolics brings together what traditional systems keep fragmented: advanced biomarker testing, clear education, and personalized coaching all integrated into a single, proactive system.

The company’s newly opened Founding Member Beta program (for Texas residents) allows early participants to experience this model firsthand. The program begins with comprehensive bloodwork that evaluates key metabolic, inflammatory, insulin resistance, and oxidative stress–related biomarkers, going far beyond standard annual panels. Participants complete testing through a nationwide network of locations with brief, convenient appointments.

From there, members receive individualized health plans and curated education that translates complex metabolic data into practical understanding, helping them see how daily choices around nutrition, movement, stress, and sleep directly impact metabolic health. Personalized coaching then helps participants turn insight into sustainable action based on their unique biology, not generic advice.

“We’re seeing a shift,” Bury added. “People aren’t looking for another program. They’re looking for clarity, and for answers to why their efforts haven’t been working and what their body is actually responding to. That’s what this system was built to provide.”

Opti Metabolics serves individuals who want to take ownership of their health early, not out of fear, but out of intention. By helping people understand metabolic function before disease develops, Opti aims to change the trajectory of long-term health.

For more information about Opti Metabolics and its Beta program, visit optimetabolics.com.

###

For more information about Opti Metabolics, contact the company here:

Opti Metabolics
Peyton Brotzman
(512) 574-8125
media@optimetabolics.com
11652 Jollyville Road
Austin, TX 78759

Recent Quotes

View More
Symbol Price Change (%)
AMZN  239.12
+0.94 (0.39%)
AAPL  255.53
-2.68 (-1.04%)
AMD  231.83
+3.91 (1.72%)
BAC  52.97
+0.38 (0.72%)
GOOG  330.34
-2.82 (-0.85%)
META  620.25
-0.55 (-0.09%)
MSFT  459.86
+3.20 (0.70%)
NVDA  186.23
-0.82 (-0.44%)
ORCL  191.09
+1.24 (0.65%)
TSLA  437.50
-1.07 (-0.24%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.